HC Wainwright & Co. Maintains Buy on Prothena Corp, Lowers Price Target to $30

Benzinga · 05/09 17:18
HC Wainwright & Co. analyst Andrew Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and lowers the price target from $48 to $30.